The diffuse esophageal spasm distinguishes from others esophageal disturbs by the symptoms severity and bad results to conservative treatment. This situation requires formal indication to surgical treatment or dilation. In high risk patients this situation becomes a big problem, due to the lack of another therapeutic option. In a patient with this problem we use an endoscopic injection of botulin toxin in cardia with good results in three months follow-up. Despite this short period of observation we believe that the infiltration with botulin toxin in cardia constitutes a valid therapeutic option in treatment of diffuse esophageal spasm
Spasticity is a component of the upper motor neuron syndrome and occurs after maladaptive improvemen...
A distonia laríngea (disfonia espasmódica) é distúrbio do movimento caracterizado por contrações inv...
Botulinum injection in the cricopharyngeal muscle has not yet been described thoroughly. In reviewin...
Endoscopic injection of botulinum toxin (BTX) has shown benefits for patients with diffuse esophagea...
International audienceEndoscopic injections of botulinum toxin in the cardia or distal esophagus hav...
The purpose of this article is to review the clinical features, pathophysiology, diagnosis, and mana...
Diffuse esophageal spasm (DES) is a rare primary motility disorder of unknown cause, that can be fou...
In achalasia and spastic esophageal motility disorders, botulinum toxin (botox) injection is conside...
Twelve patients underwent 17 endoscopic injections of botulinum toxin type A in the cricopharyngeus ...
Botulinum toxin A inhibits neuromuscular transmission. It has become a drug with many indications. T...
Achalasia represents the absence of lower esopaheal sphincter relaxation and absence of normal peris...
Although a number of the therapeutic techniques are used for the treatment of achalasia, none of the...
In six Centers belonging to the Italian Movement Disorder Study Group, the efficacy of botulinum tox...
Botulinum toxin injection is a well tolerated, safe and effective procedure in the treatment of foca...
Botulinnm toxin (BT) has been used in neurology, ophthalmology, otorhinolaryngology and gastroentero...
Spasticity is a component of the upper motor neuron syndrome and occurs after maladaptive improvemen...
A distonia laríngea (disfonia espasmódica) é distúrbio do movimento caracterizado por contrações inv...
Botulinum injection in the cricopharyngeal muscle has not yet been described thoroughly. In reviewin...
Endoscopic injection of botulinum toxin (BTX) has shown benefits for patients with diffuse esophagea...
International audienceEndoscopic injections of botulinum toxin in the cardia or distal esophagus hav...
The purpose of this article is to review the clinical features, pathophysiology, diagnosis, and mana...
Diffuse esophageal spasm (DES) is a rare primary motility disorder of unknown cause, that can be fou...
In achalasia and spastic esophageal motility disorders, botulinum toxin (botox) injection is conside...
Twelve patients underwent 17 endoscopic injections of botulinum toxin type A in the cricopharyngeus ...
Botulinum toxin A inhibits neuromuscular transmission. It has become a drug with many indications. T...
Achalasia represents the absence of lower esopaheal sphincter relaxation and absence of normal peris...
Although a number of the therapeutic techniques are used for the treatment of achalasia, none of the...
In six Centers belonging to the Italian Movement Disorder Study Group, the efficacy of botulinum tox...
Botulinum toxin injection is a well tolerated, safe and effective procedure in the treatment of foca...
Botulinnm toxin (BT) has been used in neurology, ophthalmology, otorhinolaryngology and gastroentero...
Spasticity is a component of the upper motor neuron syndrome and occurs after maladaptive improvemen...
A distonia laríngea (disfonia espasmódica) é distúrbio do movimento caracterizado por contrações inv...
Botulinum injection in the cricopharyngeal muscle has not yet been described thoroughly. In reviewin...